Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB: Safety Overview

Metric TALIMOGENE LAHERPAREPVEC TALQUETAMAB
Total FAERS Reports 1,475 515
Deaths Reported 164 81
Death Rate 11.1% 15.7%
Hospitalizations 286 224
Average Patient Age 66.7 yrs 65.7 yrs
% Female Patients 48.3% 42.4%
Manufacturer Amgen Inc Janssen Biotech, Inc.
Route INTRALESIONAL SUBCUTANEOUS